Previous studies have leveraged flank implants of immortalized human astrocytes with endogenous PPM1D truncations, or orthotopic implants of murine glioma cells exogenously expressing PPM1Dtr13,14 but have not assessed the direct contribution of mutant PPM1D to the transformation of neural stem/progenitor cells into DMG. Here, PPM1D is linked to central nervous system cancer.